Literature DB >> 25317041

Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome.

Funda Akpınar1, Berfu Demir1, Serdar Dilbaz1, Iskender Kaplanoğlu1, Berna Dilbaz1.   

Abstract

OBJECTIVE: To determine if body mass index has an effect on the outcome of in vitro fertilization in patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation.
MATERIAL AND METHODS: The study included 337 cycles. Patients were stratified into the following 3 groups: normal weight, overweight, and obese. The primary outcome measures were response to ovarian hyperstimulation, the fertilization rate, the implantation rate, and the clinical and ongoing pregnancy rates.
RESULTS: Total gonadotropin consumption increased, and the number of retrieved oocytes decreased as the body mass index increased. The implantation rate and clinical pregnancy rate were similar in all 3 groups. In response to the mid-luteal long protocol, the cycle cancellation rate was lower and the number of retrieved oocytes was higher in the overweight and obese groups, as compared to the antagonist protocol.
CONCLUSION: The body mass index did not affect the outcome of in vitro fertilization in women with polycystic ovary syndrome. Additional research is required to better understand the role of stimulation protocols on the cycle outcome.

Entities:  

Keywords:  In vitro fertilization; body mass index; polycystic ovary syndrome

Year:  2014        PMID: 25317041      PMCID: PMC4195323          DOI: 10.5152/jtgga.2014.13047

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  27 in total

1.  Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization.

Authors:  H Lashen; W Ledger; A L Bernal; D Barlow
Journal:  Hum Reprod       Date:  1999-03       Impact factor: 6.918

2.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

3.  Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.

Authors:  M Fridström; P Sjöblom; A Pousette; T Hillensjö
Journal:  Eur J Endocrinol       Date:  1997-05       Impact factor: 6.664

Review 4.  Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

Authors:  D Navot; P A Bergh; N Laufer
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

5.  GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis.

Authors:  G Griesinger; K Diedrich; B C Tarlatzis; E M Kolibianakis
Journal:  Reprod Biomed Online       Date:  2006-11       Impact factor: 3.828

6.  Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.

Authors:  A H Balen; S L Tan; J MacDougall; H S Jacobs
Journal:  Hum Reprod       Date:  1993-06       Impact factor: 6.918

Review 7.  The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation.

Authors:  Zeev Shoham
Journal:  Fertil Steril       Date:  2002-06       Impact factor: 7.329

8.  Body mass index is inversely related to intrafollicular HCG concentrations, embryo quality and IVF outcome.

Authors:  Douglas T Carrell; Kirtly P Jones; C Matthew Peterson; Vincent Aoki; Benjamin R Emery; Bruce R Campbell
Journal:  Reprod Biomed Online       Date:  2001       Impact factor: 3.828

9.  The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.

Authors:  B C Tarlatzis; G Grimbizis; F Pournaropoulos; J Bontis; S Lagos; E Spanos; S Mantalenakis
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918

10.  Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index.

Authors:  Betsy McCormick; Michael Thomas; Rose Maxwell; Daniel Williams; Mira Aubuchon
Journal:  Fertil Steril       Date:  2008-01-14       Impact factor: 7.329

View more
  4 in total

Review 1.  Impact of obesity on infertility in women.

Authors:  Zeynep Özcan Dağ; Berna Dilbaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

2.  Predictors of pregnancy after intrauterine insemination in women with polycystic ovary syndrome.

Authors:  Hui-Juan Guan; Lin-Qing Pan; Hang Song; Huai-Yun Tang; Li-Sha Tang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

3.  The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome.

Authors:  Funda Akpinar; Berna Dilbaz; Derya A Cırık; Saynur Yilmaz; Sadiman Kiykac; Ertugrul Karahanoglu; Leyla Mollamahmutoglu
Journal:  Saudi Med J       Date:  2016-11       Impact factor: 1.484

4.  Effects of pre-pregnancy body mass index on pregnancy and perinatal outcomes in women with PCOS undergoing frozen embryo transfer.

Authors:  Jiaying Lin; Jialyu Huang; Ningling Wang; Yanping Kuang; Renfei Cai
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-10       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.